HEADER RNA BINDING PROTEIN 27-APR-06 2DO0 TITLE SOLUTION STRUCTURE OF THE RNA BINDING DOMAIN OF HETEROGENEOUS NUCLEAR TITLE 2 RIBONUCLEOPROTEIN M COMPND MOL_ID: 1; COMPND 2 MOLECULE: HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RNA RECOGNITION MOTIF; COMPND 5 SYNONYM: HNRNP M; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HNRPM; SOURCE 6 EXPRESSION_SYSTEM: CELL FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: P050719-20; SOURCE 9 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS RNA RECOGNITION MOTIF, RRM, RNA BINDING DOMAIN, RBD, RNP, STRUCTURAL KEYWDS 2 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 3 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, RNA BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.SUZUKI,Y.MUTO,M.INOUE,T.KIGAWA,T.TERADA,M.SHIROUZU,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2DO0 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DO0 1 VERSN REVDAT 1 27-OCT-06 2DO0 0 JRNL AUTH S.SUZUKI,Y.MUTO,M.INOUE,T.KIGAWA,T.TERADA,M.SHIROUZU, JRNL AUTH 2 S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE RNA BINDING DOMAIN OF JRNL TITL 2 HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DO0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000025638. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.1MM 13C/15N-PROTEIN; 20MM D REMARK 210 -TRIS-HCL(PH7.0); 100MM NACL; REMARK 210 1MM D-DTT; 0.02% NAN3; 90% H2O, REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20031121, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9321, OLIVIA 1.10.5, REMARK 210 CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYANAMICS, REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY, STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 280 99.26 -65.15 REMARK 500 1 PHE A 287 131.47 -174.18 REMARK 500 1 PRO A 290 96.07 -69.76 REMARK 500 1 PRO A 293 93.08 -69.74 REMARK 500 1 PRO A 298 85.96 -69.75 REMARK 500 1 SER A 300 112.92 -161.53 REMARK 500 2 LEU A 201 96.86 -47.53 REMARK 500 2 SER A 203 46.86 -101.22 REMARK 500 2 ARG A 243 36.35 -97.10 REMARK 500 3 SER A 192 43.59 34.73 REMARK 500 3 PRO A 298 2.60 -69.80 REMARK 500 4 ALA A 198 178.23 -55.09 REMARK 500 4 SER A 203 52.07 -116.64 REMARK 500 4 PHE A 287 39.81 -97.66 REMARK 500 5 SER A 193 -55.66 -123.38 REMARK 500 5 THR A 204 114.61 -34.61 REMARK 500 5 LYS A 213 40.17 -85.53 REMARK 500 5 ARG A 231 119.80 -160.58 REMARK 500 5 LYS A 238 -30.90 -35.78 REMARK 500 5 ARG A 243 35.88 -93.17 REMARK 500 5 PRO A 293 -176.14 -69.70 REMARK 500 6 SER A 189 139.46 -171.65 REMARK 500 6 ALA A 195 -72.73 -60.65 REMARK 500 6 ARG A 231 117.83 -161.35 REMARK 500 6 ASP A 270 31.45 72.13 REMARK 500 6 PRO A 283 -178.24 -69.76 REMARK 500 6 ASP A 286 101.74 -59.59 REMARK 500 6 SER A 296 141.65 -174.65 REMARK 500 6 SER A 300 116.27 -167.46 REMARK 500 7 SER A 189 42.31 39.48 REMARK 500 7 ALA A 195 -179.56 -52.82 REMARK 500 7 ASP A 278 151.85 -43.05 REMARK 500 7 LEU A 282 139.65 -38.90 REMARK 500 7 PRO A 298 -176.58 -69.82 REMARK 500 8 LEU A 196 -60.32 -90.96 REMARK 500 8 ALA A 198 -51.84 -129.56 REMARK 500 8 ARG A 231 117.87 -163.81 REMARK 500 9 SER A 189 139.63 -170.35 REMARK 500 9 ALA A 195 117.70 -163.93 REMARK 500 9 LEU A 201 41.07 -105.14 REMARK 500 9 SER A 203 44.21 -95.07 REMARK 500 9 ARG A 243 35.38 -95.92 REMARK 500 9 PRO A 283 96.31 -69.80 REMARK 500 9 PHE A 287 118.71 -164.33 REMARK 500 9 PRO A 290 5.36 -69.75 REMARK 500 9 PRO A 298 96.53 -69.77 REMARK 500 9 SER A 300 131.48 -171.92 REMARK 500 10 THR A 204 129.66 -34.87 REMARK 500 10 ARG A 231 118.58 -168.56 REMARK 500 10 LYS A 238 -28.90 -39.70 REMARK 500 REMARK 500 THIS ENTRY HAS 110 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK003002075.1 RELATED DB: TARGETDB DBREF 2DO0 A 195 295 UNP P52272 HNRPM_HUMAN 195 295 SEQADV 2DO0 GLY A 188 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 189 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 190 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 GLY A 191 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 192 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 193 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 GLY A 194 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 296 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 GLY A 297 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 PRO A 298 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 299 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 SER A 300 UNP P52272 CLONING ARTIFACT SEQADV 2DO0 GLY A 301 UNP P52272 CLONING ARTIFACT SEQRES 1 A 114 GLY SER SER GLY SER SER GLY ALA LEU GLN ALA GLY ARG SEQRES 2 A 114 LEU GLY SER THR VAL PHE VAL ALA ASN LEU ASP TYR LYS SEQRES 3 A 114 VAL GLY TRP LYS LYS LEU LYS GLU VAL PHE SER MET ALA SEQRES 4 A 114 GLY VAL VAL VAL ARG ALA ASP ILE LEU GLU ASP LYS ASP SEQRES 5 A 114 GLY LYS SER ARG GLY ILE GLY THR VAL THR PHE GLU GLN SEQRES 6 A 114 SER ILE GLU ALA VAL GLN ALA ILE SER MET PHE ASN GLY SEQRES 7 A 114 GLN LEU LEU PHE ASP ARG PRO MET HIS VAL LYS MET ASP SEQRES 8 A 114 GLU ARG ALA LEU PRO LYS GLY ASP PHE PHE PRO PRO GLU SEQRES 9 A 114 ARG PRO GLN GLN SER GLY PRO SER SER GLY HELIX 1 1 TRP A 216 PHE A 223 1 8 HELIX 2 2 SER A 253 PHE A 263 1 11 SHEET 1 A 4 VAL A 229 LEU A 235 0 SHEET 2 A 4 ILE A 245 PHE A 250 -1 O THR A 247 N ASP A 233 SHEET 3 A 4 THR A 204 ALA A 208 -1 N VAL A 205 O VAL A 248 SHEET 4 A 4 HIS A 274 MET A 277 -1 O LYS A 276 N PHE A 206 SHEET 1 B 2 LEU A 267 LEU A 268 0 SHEET 2 B 2 ARG A 271 PRO A 272 -1 O ARG A 271 N LEU A 268 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1